New CDC data on falling rates of precancerous cervical lesions in the U.S. underscore the benefits of HPV vaccination.

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually transmitted infection that affects both females and males and is linked to higher risks of various forms of cancer.

A new CDC report finds that rates of precancerous lesions detected in women ages 20 to 24 have decreased by nearly 80%, lesions that would likely develop into cervical cancer years later.

Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate the disease within years.

A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened for cervical cancer.

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus (HPV) vaccine.   Rates of precancerous lesions in women between

HPV vaccination efforts have significantly reduced the rates of precancerous cervical lesions among women, particularly those aged 20-24, showing an 80% decrease. Continued screening and prevention are essential,

Cervical precancer rates dropped precipitously among young women who underwent screening after the human papillomavirus (HPV) vaccine was first recommended in the U.S., CDC researchers reported. Among women ages 20 to 24 who were screened for cervical cancer from 2008 to 2022,

SrdjanPav/Getty Images A recent CDC report builds on existing evidence showing the effectiveness of the HPV vaccine for preventing cervical cancer. While HPV is commonly associated with females ...